San Jose, Calif. – August 10, 2012 - MIBA Medical Inc., a medical aesthetics company, today announced that it had selected Comparative Bioscience for its pre-clinical testing and research work.

Comparative Bioscience Inc, (CBI) is lead by Founder and CEO Carol Meschter, DVM, PhD, DACVP. CBI "mission is to provide the best quality preclinical laboratory services to our clients in the biopharmaceutical and medical device industries on the West Coast and beyond. This mission will be achieved through our commitment to customer service, scientific quality, and employee satisfaction. Accomplishment of our mission will result in the long-term growth of CBI, the creation of value for all stakeholders in our company, success for our clients, and better health for humans and animals worldwide."

BaoTran, VP Legal Affairs noted that we are very happy that CBI will put their wealth of experience to work for MIBA ".

About MIBA Medical Inc.

MIBA Medical Inc. is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. For more information, please visit http://www.mibamedical.com.